Paradise J L
Children's Hospital of Pittsburgh, PA 15213-2583, USA.
Pediatrics. 1995 Oct;96(4 Pt 1):712-5.
Given the increasing prevalence of multiply resistant pneumococcal infection and the heightened risks associated with antimicrobial usage, antimicrobial treatment of otitis media in children should be restricted generally to the extent possible without compromising individual children's well-being and without subjecting them to risks potentially greater than the risks associated with antimicrobial usage. Not infrequently the decisions required will be difficult and matters of judgment. However, in most cases the indications for initiating or prolonging antimicrobial treatment will be either straightforward, calling for a decision to proceed, or marginal, in which case the decision not to proceed should be clear.
鉴于多重耐药肺炎球菌感染的患病率不断上升以及抗菌药物使用相关风险增加，儿童中耳炎的抗菌治疗通常应尽可能加以限制，前提是不损害个体儿童的健康，且不使他们面临可能大于抗菌药物使用相关风险的潜在风险。通常需要做出的决策会很困难，属于判断问题。然而，在大多数情况下，启动或延长抗菌治疗的指征要么很明确，需要做出继续治疗的决定，要么处于边缘情况，在这种情况下，不继续治疗的决定应该很明确。
